BOSTON–(BUSINESS WIRE)–AI Proteins, a biotech company pioneering a new class of de novo medicines built from the ground up using artificial intelligence, today announced the closing of a $41.5 million Series A financing. The round was led…
According to filings with the U.S. Securities and Exchange Commission, AI Proteins is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management Co-Founder, Chris Bahl played a key role in securing…
Andover, MA – According to filings with the U.S. Securities and Exchange Commission, AI Proteins is raising $18,205,000.00 in new funding. Sources indicate as part of senior management Co-Founder, Chris Bahl played a key role…